Association of HIV with Breast Abscess and Altered Microbial Susceptibility Patterns by Kapatamoyo, B et al.
ORIGINAL PAPER
Association of HIV with Breast Abscess and Altered 
Microbial Susceptibility Patterns
1 2,3 1*B. Kapatamoyo , B. Andrews , K. Bowa
*Corresponding author 
Bernard Kapatamoyo 
University of Zambia, 
Department of Surgery, Lusaka, Zambia
Email: benkapatamoyo@yahoo.com
1
2University of Zambia, Department of Internal Medicine, Lusaka, Zambia, 
3Vanderbilt University, Institute for Global Health, Nashville, TN, USA
University of Zambia, Department of Surgery, Lusaka, Zambia, 
ABSTRACT
Background: Breast abscesses account for 15% of 
surgical day cases seen in the University Teaching 
Hospital (UTH) in Lusaka, Zambia. Nearly all of 
these cases occur in lactating women. Pre-natal HIV 
prevalence among women seeking care at UTH was 
estimated at 25% as of 2004. Baseline surveys have 
shown that up to 60% of soft tissue infections 
presenting to the UTH are HIV related. 
Objectives: To determine if HIV infection is a risk 
factor for the development of breast abscesses in 
women presenting to the (UTH). Secondary 
objective was to identify bacteriological aetiologies 
and drug sensitivity patterns associated with breast 
abscesses at UTH. 
Study Design: A case-control study of 110 
consecutive breast-feeding mothers diagnosed with 
breast abscess upon presentation to the UTH 
surgical service (cases) and 110 representative 
controls recruited from the UTH postnatal clinic. 
Main Outcomes:  HIV seropositivity and CD4 
counts (if HIV positive) among cases and controls.
Results: Fifty-four out of 110 (49.1%) lactating 
women with breast abscess had positive serologic 
tests for HIV. Only 25 of 110 (23%) control women 
tested HIV positive. This difference was statistically 
significant, with an odds ratio of 3.28 (95% CI 1.83 – 
5.87; p = 0.001). Mean CD4 counts in cases were 
lower than in controls (338 vs. 568, p<0.001). 
Staphyloccocus aureus was the main causative agent 
(91.8%) of isolates.  Among S. aureus isolates, 70 of 
101 (69.3%) were oxacillin susceptible. Forty-three 
of 50 (86.0%) specimens from HIV positive patients 
were resistant to SMX-TMP compared with only 
61% of specimens from HIV negative patients 
(p=0.004). 
Conclusions: HIV infection appears to be a 
significant risk factor in the development of breast 
abscess in lactating women in Zambia.  
Staphylococcus aureus remains the main causative 
agent, with MRSA accounting for 30.7% of isolates. 
SMX-TPM resistance likely stems from the wide 
spread use of the drug for PCP prophylaxis in HIV 
positive patients. It therefore should not be used for 
treatment of acute bacterial infections. HIV related 
breast infections could be considered as a possible 
entry point to HIV treatment now that the CD4 
treatment guidelines have been adjusted to 
350cells/cmm, although this requires further studies 
for validation. 
INTRODUCTION 
Lactational abscesses account for 15% of surgical 
infections presenting to the emergency female 
admission wards of the University Teaching 
Hospital (UTH) in Lusaka.  Paucity of data on the 
subject, especially in sub-Saharan Africa, makes 
s c i e n t i f i c  s t a t i s t i c a l  c o m p a r i s o n s  a n d  
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generalisations on such a high frequency of cases 
difficult.  A local study showed that up to 60% of 
patients presenting to the UTH for surgical 
treatment of soft tissue infections were HIV positive 
(Sikasote Chomba unpublished, UTH 1997).  
The need for epidemiological and bacteriological 
data for such a widespread community acquired 
infection is compelling. The possible association of 
breast infections with HIV cannot be completely 
ignored as the prevalence of HIV in our general 
population still remains high (16%), with a higher 
1rate in ante-natal women (25%) . This is also a 
source of mother to child transmission of HIV. This 
is compounded by the fact that exclusive breast 
feeding for the first six months is encouraged 
worldwide to all mothers, especially in resource 
constrained areas. It is believed to reduce morbidity 
2and mortality in infants born from infected mothers . 
Early diagnosis and treatment of breast infections 
may help mitigate the increased risk of transmission 
associated with breast ulcerative pathologies. No 
studies, to our knowledge, are available that 
associate HIV with increased risk of breast 
infections in particular. However, studies have 
shown an increased risk of pyogenic skin infections 
3
in patients with CD4 counts below 200cells/cmm .
The effect of such a high disease burden in a 
resource limited public institution like the UTH is 
far reaching, from inadequate qualified surgical 
personnel to the cost of surgical care. Data is needed 
for clinical and interventional planning to help deal 
with the infection before it complicates beyond 
mastitis. 
We sought to determine the HIV seroprevalence of 
women presenting to UTH with breast abscess and 
to assess if HIV infection is a risk factor for abscess 
development. Secondary objective was to identify 
bacterial and drug sensitivity patterns associated 
with breast abscesses at UTH and to compare these 
findings in HIV positive and negative women. 
MATERIALS AND METHODS
A prospective case-control study was performed to 
evaluate the association between HIV and breast 
infection.
From November 2008 to February 2009, we 
screened consecutive patients presenting to the 
surgical admission ward of University Teaching 
Hospital with signs and symptoms of breast 
infection. The UTH is the only public hospital in the 
district with theatre capabilities and hence receives 
referrals for all complicated and many 
uncomplicated cases of mastitis requiring surgical 
intervention. 
Breast abscess was defined as a fluctuant 
inflammatory tender breast mass with positive 
needle aspiration of pus. Patients were included as 
cases if they had a confirmed diagnosis of breast 
abscess, were lactating, and lived in Lusaka district. 
Patients were excluded if they had a previous 
diagnosis of diabes or resided outside of Lusaka 
district. The control group consisted of breast 
feeding women attending antenatal clinic at UTH. 
The case and control groups were frequency 
matched to control for patient age, education level, 
and parity. Written informed consent was obtained 
from all case and control patients. The study was 
approved by the University of Zambia Research 
Ethics Committee.
Epidemiological data was collected by a standard 
questionnaire applied to both sets of clients. 
The following specimens were collected: 
1. Blood for HIV antibody testing, and 
reflexive CD4 count if HIV test was 
positive
2. Pus Aspirates for microscopy, culture, and 
sensitivity.
Specimens were analyzed at the UTH virology labs. 
HIV tests were performed using the Determine® 
HIV-1/2 antibody test (Inverness Medical 
Innovations, Cranfield, UK) for screening and Uni-
Gold Recombigen® HIV Test (Trinity BioTech, 
Bray, Ireland) for confirmation. CD4 counts were 
done by FACS calibur machine and blood was 
stained using CD3 FITC, CD4 PE and CD45 
PERCP monoclonal Abs.  Pus aspirates were 
cultured on Mueller-Hinton agar.  We tested drug 
susceptibilities of standard antibiotics currently 
recommended by government for use in public 
clinics for first and second line management of 
infections. Kirby-Bauer disk diffusion method was 
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used, and MIC resistance cutoffs were obtained 
from the Clinical and Laboratory Standards Institute 
Quality Manual, 2008 edition (CLSI, Wayne, PA, 
USA). 
Using EPI-INFO 6 Stat calc (Centers for Disease 
Control and Prevention (CDC), Atlanta, GA, USA), 
we estimated that we would need a sample size of 
375 total patients in order to achieve an 80% power 
to detect an odds ratio of 2.0 or more with an alpha of 
0.05.  
In our pre-study survey, a total of 236 cases of breast 
abscess were seen in seven months. Based on time 
constraints, however, we limited our study to 110 
case patients meeting inclusion criteria over the 
course of 3months and 110 controls. 
Characteristics of cases and controls were compared 
using Chi squared test or Fisher's exact test for 
categorical variables and student's t test for 
continuous variables. All variables with a p value of 
< 0.1 were included in a logistic regression model to 
further assess association with abscess. Analyses 
were performed using SPSS Version17 (SPSS, Inc., 
Chicago, IL, USA). P value of less than 0.05 was 
considered statistically significant.
RESULTS 
One hundred ten cases of breast abscess were 
identified along with one hundred ten postnatal 
controls. Baseline characteristics of cases and 
controls are shown in Table 1.  Patients ranged in age 
from 16 to 34 with an average age of 23 years. 
Eighty-six percent were married. The majority of 
women lived in high-density neighbourhoods 
(74%), were employed (63%) and had only one child 
(53%). Eighty percent of women had a child less 
than six months of age. Twenty-five percent of 
patients endorsed drinking alcohol, but only 3% of 
patients readily admitted to smoking cigarettes. 
There was a trend towards increased alcohol use 
among case patients, although not statistically 
significant (OR 1.82, 95%CI 0.97-3.40).
Table 1: Baseline characteristics of cases and 
controls
Primary outcomes
Fifty-four out of 110 (49.1%) lactating women with 
breast abscess had positive serologic tests for HIV. 
Only 24 of 110 (21.8%) control women tested HIV 
positive. This difference was statistically significant, 
with an odds ratio of 3.46 (95% CI 1.92 – 6.21; p = 
0.001). In a multivariate logistic regression analysis 
that included all of the variables in Table 1 except for 
CD4 count, HIV status remained significant (OR 
3.20, 95%CI 1.71 – 5.98). Mean CD4 counts among 
HIV positive women with breast abscess was 
3338cells/mm  (range: 59 to 850) and for HIV 
positive controls were 568 cells/cmm (range: 420 to 
712; p<0.001). Forty-one out of 54 (76%) HIV 
positive case patients had CD4 counts between 201 
and 500. Only six (11%) had CD4 at or below 200, 
and the remaining seven patients (13%) had CD4 
counts greater than 500. None of the control patients 
had CD4 counts less than 200.
Secondary outcomes
Microbiologic results
Pus aspirates were obtained from all 110 cases and 
were cultured for identification of organisms. Drug 
susceptibility testing was performed for oxacillin 
and for commonly available antibiotics. Results 
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remaining 108 samples, 101 (91.8%) grew 
Staphylococcus aureus, one sample (0.9%) grew 
bacillus species and one sample (0.9%) grew 
Streptococcus pyogenes. Five samples (4.5%) were 
culture negative. 
Among S. aureus isolates, 70 of 101 (69.3%) were 
oxacillin susceptible, while the remaining 31 
(30.7%) were oxacillin-resistant (MRSA). Twenty-
seven (26.7%) and fifty-three (52.5%) isolates were 
susceptible to sulfamethoxazole-trimethoprim 
(SMX-TMP) and tetracycline, respectively. 
Chloramphenicol (93%), erythromycin (95%), and 
ciprofloxacin (99%) had in vitro activity against 
more than ninety percent of isolates.
Figure 1 shows S. aureus drug susceptibilities by 
HIV serostatus. Forty-three of 50 (86.0%) 
specimens from HIV positive patients were resistant 
to SMX-TMP compared with only 61% of HIV 
negative patients (p=0.004). There were no other 
significant differences in drug susceptibilities 
between HIV positive and negative patient isolates.
DISCUSSION
International literature shows mastitis to be 
common between 5%-33%, with complication rates 
4-7
between 1-3% . Most complications have been 
attributed to delayed treatment of mastitis and not 
HIV immunosuppression. Although recurrent 
Figure 1
pyogenic skin infections are a known feature of 
severe immunosuppression (CD4>200cells/cmm), 
there are no studies that directly ascribe 
development of mastitis and breast abscesses to HIV 
3
infection . 
In our study we found a significant association 
between HIV infection and development of breast 
infections (Odds ratio 3.46). This association was 
not affected by other measured variables in a logistic 
regression model (OR 3.77). We also found lower 
mean CD4 counts amongst HIV+ cases compared 
with HIV +controls.  The majority of HIV positive 
patients with breast abscess had CD4 counts 
between 200 and 500. Our findings demonstrate that 
mild to moderate immunosuppression predisposes 
HIV positive patients to soft tissue infections. 
Patients do not need to progress to AIDS in order to 
be at risk for breast abscess.  Only 6 patients with 
abscesses had CD4 counts (< 200) that would 
qualify for AIDS.  
Several risk factors have already been identified to 
be associated with the development of mastitis. 
These include cigarette smoking( in non lactating 
women), anaemia, diabetes, use of steroids, fatigue, 
low socio-economic status, state of reduced 
immunity not specified as HIV infection, 
8-10postpartum pelvic infection . In our study cigarette 
smoking was not significantly associated with 
mastitis (p=0.70). Smoking is culturally not a 
common habit in women in Zambia. Alcohol 
consumption, however, is somewhat common, and 
we found a trend toward association between 
alcohol use and abscess. Age of breast feeding child 
(0-6months) was also not a significant factor 
4
although observed internationally . Most cases seen 
were in employment which may be a source of 
mother fatigue.  
The predominance of Staphyloccocus aureus as a 
cause of breast abscesses in this study was 
consistent with previous studies that examined 
11, 12breast infections  . Whereas those studies 
described women with both complicated and 
uncomplicated mastitis, our study included only 
those with breast abscess. 
The proportion of S. aureus isolates in our study that 
were MRSA by oxacillin testing (30.7%) was 
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comparable with studies performed in South 
13Africa . To our knowledge, ours is the first 
published study to describe rates of MRSA infection 
in Zambia. When there is minimal cellulitis 
surrounding a breast abscess, surgical management 
without antibiotics is generally sufficient. For 
cellulitis of the breast and other areas of the body, 
however, treatment usually consists of cloxacillin or 
cephalexin. Our findings suggest that in soft tissue 
infections complicated by abscess formation, if 
antibiotics are required they should include MRSA 
coverage, particularly in severe or life-threatening 
infections. 
The choice of antibiotic for MRSA coverage is 
complicated. In other parts of the world, SMX-TMP 
is used frequently for community-acquired MRSA 
treatment. In the United States, for example, studies 
have found that 95-99% of methicillin-susceptible 
and -resistant S. aureus strains were SMX-TMP 
14,15susceptible . Our study found very high rates 
(73.3%) of SMX-TMP resistance, with even higher 
resistance rates (86.0%) seen in HIV positive 
patients.  This finding reflects the widespread use of 
the drug in HIV positive patients for the prophylaxis 
of pneumocystis, toxoplasma, and bacterial 
infections. WHO guidelines recommend SMX-TMP 
for all HIV positive patients with stage 2 disease or 
higher regardless of CD4 count.  This has been an 
effective strategy, but its impact on resistance 
profiles needs to be considered when empirically 
treating bacterial infections. 
Consequently, drugs other than SMX-TMP should 
be used for treating S. aureus or suspected S. aureus.  
Our study found that staph isolates were most likely 
to be susceptible in vitro to chloramphenicol, 
erythromycin, or ciprofloxacin.  The high 
susceptibilities to these drugs are contrary to 
14,16findings from Great Britain and the U.S. . Staph 
aureus isolates from nearby South Africa have 
13,17
shown variable resistance patterns . In KwaZulu-
Natal province, for example, overall rates of 
resistance were 30% for erythromycin and 5% for 
chloramphenicol and ciprofloxacin, but much 
higher in the methicillin-resistant strains. 
Nationwide, 70-80% of MRSA strains were resistant 
17
to erythromycin or ciprofloxacin .  The extremely 
low rates of resistance to these drugs in our study 
might reflect a difference in regional antimicrobial 
usage and subsequent epidemiology. Erythromycin, 
ciprofloxacin, and chloramphenicol should be 
considered, alone or in combination for treatment of 
suspected staphylococcal soft tissue infections. 
Clindamycin, although not assessed in this study, is 
another possible alternative. 
There were several limitations in our study. As in 
any case-control study, the selection of controls has 
a strong bearing on the results. The CD4 counts 
among our controls were higher than might be 
expected from our general population. This may 
reflect the fact that women with lower CD4 counts 
may have been diagnosed during pregnancy and 
received ART for some duration. We did not assess 
the use of antiretrovirals among our cases or control 
patients. Although our case patients were referred 
from throughout Lusaka, our controls were patients 
who specifically receive postnatal care at UTH and 
might not be representative of the neighbourhoods 
where case patients live. However, the proportion of 
patients from high-density neighbourhoods was 
similar in the two groups. 
CONCLUSION
HIV infection appears to be a significant risk factor 
in the development of breast infections in lactating 
women presenting to the UTH (Lusaka).  
Staphylococcus aureus remains the main causative 
agent with MRSA accounting for (30.7%) of 
isolates. Sulfamethoxazole-trimethoprim resistance 
(74.3%) likely stems from the wide spread use of the 
drug for PCP prophylaxis in HIV positive patients. It 
therefore should not be used for treatment of acute 
bacterial infections. All women in Zambia with 
lactational breast abscess should be tested for HIV. 
HIV-related breast infections could be considered as 
a possible entry point to HIV treatment now that the 
CD4 treatment guidelines have been adjusted to 
350cells/cmm, although this requires further studies 
for validation.
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